Patients with severe mental illnesses, such as schizophrenia and bipolar disorder, often require long-term use of ...

In a recent British Medical Journal study, researchers assess the adverse effects associated with the use of antipsychotic drugs in people with dementia. Study: Multiple adverse outcomes associated ...

The new approval is the first for the drug under JNJ leadership. ・The drug is also approved for the treatment of bipolar I ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

Prescriptions of antipsychotic drugs increased for people with dementia substantially in the initial months of the pandemic and remained elevated in 2021, according to a study published in the journal ...

Expensive new antipsychotic drugs that are among the most widely prescribed pills in medicine are no more effective and no safer than an older, cheaper drug that has been largely discontinued, ...

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive deficits. Group therapy may be a new, promising intervention.

Antipsychotic use among Medicaid-insured children from low- or very-low-income families skyrocketed in just under a decade, new research shows. Investigators from the University of Maryland in ...

Last month I wrote an open letter, as Chair of the International Institute of Psychiatric Drug Withdrawal, requesting that the UK’s National Institute for Health and Care Excellence (NICE) reverse its ...